BioPharma Credit rises 2.9% after $762m London IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityEquity IPOs

BioPharma Credit rises 2.9% after $762m London IPO

Shares in BioPharma Credit, the UK closed end investment fund focused on the debt of life sciences companies, closed 2.9% above their IPO price on Thursday when they started trading in London on Thursday after the company finished its $762m IPO.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article